DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Monagle P, Lensing AWA, Thelen K. et al; EINSTEIN-Jr Phase 2 Investigators.
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.
Lancet Haematol 2019;
6 (10) e500-e509
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.